These findings suggest that EphA5 may play a regulatory role in early tumor progression, particularly through interactions with key signaling molecules such as pAMPK, pAkt, and pStat3, warranting further mechanistic investigation (Table S1). The gene discussed is EPHA5; the disease is neoplasm.